Dyadic International, Inc. (DYAI)
$0.41-4.65%Close
SELLCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $15M
- Beta
- 1.15
- P/E (TTM)
- -1.92
- Short % float
- 0.66%
- Days to cover
- 1.0
- SI change
- -21.2%
- 1W
- -10.87%
- 1M
- -4.65%
- vs SPY 1W
- -10.73%
- vs SPY 1M
- -7.16%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 28
- VALUE
- 15
- GROWTH
- 18
- GARP
- 80
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-116.6%
GROSS30
OP-214
NET-219
[VALUATION]
P/E TTM-1.92
P/E FWD15.47
SECTOR PE20.48
INDUSTRY PE13.99
P/B-6.26
P/FCF-
EV/EBITDA-2.79
EV/EBIT-
PEG0.08
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.65
ND/EBITDA-
BETA1.15
Company news
FAQ
- What is LOPJLB’s current signal on DYAI?
- LOPJLB’s latest quantitative signal on Dyadic International, Inc. (DYAI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is DYAI in?
- Dyadic International, Inc. (DYAI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Dyadic International, Inc. (DYAI) do?
- Dyadic International, Inc. operates as a U.S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activities are underpinned by a patented and proprietary C1 platform, alongside other advanced technologies. This technological foundation drives their research, development, and commercial endeavors, focus…